image
ImmunityBio, Inc. IBRX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 4.49
-7.8 %
$ 3.13 B
Market Cap
-5.41
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 159.17% -39.75% -3.12%
Annual Report FY 10-K 2022-12-31 -74.30% -19.29% -6.36%
Annual Report FY 10-K 2021-12-31 54.38% -56.05% -49.53%
Annual Report FY 10-K 2020-12-31 -72.52% -39.98% -41.36%
Annual Report FY 10-K 2019-12-31 4585.11% -66.44% -58.81%
Annual Report FY 10-K 2018-12-31 4.44% 0.20% 0.74%
Annual Report FY 10-K 2017-12-31 2.27% 20.19% 20.39%
Annual Report FY 10-K 2016-12-31 -81.36% 49.00% 47.88%
Annual Report FY 10-K 2015-12-31 -63.18% -3712.59% -3745.40%
Annual Report FY 10-K 2014-12-31 6.83% -203.52% -173.78%
Annual Report FY 10-K 2013-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 7160.98% 10.31% -0.15%
Quarterly Report Q2 8-K 2024-06-30 2453.66% 2.40% -16.66%
Quarterly Report Q1 8-K 2024-03-31 -88.89% 11.28% 14.68%
Quarterly Report Q4 8-K 2023-12-31 90.41% -115.45% 0.47%
Quarterly Report Q3 8-K 2023-09-30 -30.51% 13.84% 11.75%
Quarterly Report Q2 8-K 2023-06-30 17.14% -45.77% -6.94%
Quarterly Report Q1 8-K 2023-03-31 2471.43% -47.01% -16.26%
Quarterly Report Q4 8-K 2022-12-31 -81.28% -18.70% -7.10%
Quarterly Report Q3 8-K 2022-09-30 78.79% -26.60% -15.18%
Quarterly Report Q2 8-K 2022-06-30 -89.68% -7.14% 7.31%
Quarterly Report Q1 8-K 2022-03-31 -89.93% -29.16% -11.25%
Quarterly Report Q4 8-K 2021-12-31 365.31% -34.66% -17.64%
Quarterly Report Q3 8-K 2021-09-30 -56.29% -33.57% -19.67%
Quarterly Report Q2 8-K 2021-06-30 -22.25% -71.64% -68.72%
Quarterly Report Q1 8-K 2021-03-31 -15.76% -114.95% -135.04%
Quarterly Report Q4 8-K 2020-12-31 -15.98% -204.23% -215.52%
Quarterly Report Q3 8-K 2020-09-30 1158.33% -320.91% -322.94%
Quarterly Report Q2 8-K 2020-06-30 2464.71% -208.35% -205.25%
Quarterly Report Q1 8-K 2020-03-31 3200.00% -107.09% -104.83%
Quarterly Report Q4 8-K 2019-12-31 13042.86% -28.47% -23.29%
Quarterly Report Q3 8-K 2019-09-30 -61.29% 34.06% 34.04%
Quarterly Report Q2 8-K 2019-06-30 325.00% 39.85% 39.89%
Quarterly Report Q1 8-K 2019-03-31 0.00% 35.01% 35.10%
Quarterly Report Q4 8-K 2018-12-31 -41.67% 29.19% 29.65%
Quarterly Report Q3 8-K 2018-09-30 287.50% 1.39% 0.26%
Quarterly Report Q2 8-K 2018-06-30 -71.43% -18.25% -18.47%
Quarterly Report Q1 8-K 2018-03-31 -54.55% -12.25% -12.35%
Quarterly Report Q4 8-K 2017-12-31 -14.29% -1.03% -1.13%
Quarterly Report Q3 8-K 2017-09-30 -33.33% 24.86% 25.83%
Quarterly Report Q2 8-K 2017-06-30 16.67% 31.02% 31.56%
Quarterly Report Q1 8-K 2017-03-31 83.33% 20.02% 20.19%
Quarterly Report Q4 8-K 2016-12-31 0.00% 68.45% 68.43%
Quarterly Report Q3 8-K 2016-09-30 20.00% 25.21% 25.16%
Quarterly Report Q2 8-K 2016-06-30 -86.81% 59.81% 59.54%
Quarterly Report Q1 8-K 2016-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2015-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2015-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2015-06-30 0.00% 0.00% 0.00%